BLM and Miyoshi myopathy: Additionally, we did not find any correlation between the sensitivity to the BLM inhibitor and the MM molecular subgroups (65), nor the recurrent mutations reported in MM, nor mutations in genes involved in the DDR (66, 79) (Figure 3D).